![]() |
Clinical Image
1 Cardiologist, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
2 Retired Internist and Geriatrician, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
Address correspondence to:
Mark Rabinovitch
MD, 1980 Sherbrooke St. West, Montreal, Quebec H3H 1E8,
Canada
Message to Corresponding Author
Article ID: 100071Z09MR2022
No Abstract
Keywords: Gold ring, Heberden’s node, Osteoarthritis
At a routine annual checkup, an otherwise healthy 71-year-old man was noted to have painless nodal osteoarthritis with large Heberden’s nodes at the distal interphalangeal joint (DIP) of each of his fingers except for the left fourth finger. He had worn a 14-Karat gold wedding band on that finger for the previous 38 years. To document this finding radiographically, plain X-rays of the hands were acquired. The catcher’s view and posterior to anterior (PA) film showed prominent osteophytes at the DIP joints of nine fingers with only limited sclerosis of the left 4th DIP joint (Figure 1 and Figure 2).
Systemic gold therapy has been used in the treatment of rheumatoid arthritis [1]. It is now understood that gold inhibits the production of proinflammatory cytokines [2] and reduces oxidative stress [3]. Systemic toxicity now limits its use [1]. Three prior publications had documented the apparent protective effect of a gold ring in erosive arthritis [4],[5],[6]. In the first case report by Bolosiu and Parasca [4], a 54-year-old female with Sjogren’s syndrome and rheumatoid arthritis of 25 years duration showed sparing from erosive changes in the proximal interphalangeal (PIP) joint of the left ring finger. Bolosiu [7] later hypothesized that the sparing of the PIP joint in their patient was not from the gold in the ring but was from a mechanical effect of the ring. In the second report by Mulherin et al. [5], 30 gold ring wearers with rheumatoid arthritis had less articular erosion at their adjacent metacarpal-phalangeal (MCP) joint than 25 non-ring wearers with rheumatoid arthritis at their MCP joint. The authors hypothesized that gold could pass from the ring through the skin and local lymphatics downstream to the local MCP joint to delay articular erosion. In the third case report by Hlaing et al. [6], a 49-year-old female with psoriatic arthritis was found to have joint space narrowing and extensive synovitis with articular erosions at the PIP joints of all the fingers sparing the left ring finger PIP joint. The patient had worn a gold wedding ring on the left ring finger for the previous 26 years. They proposed 5 separate mechanisms for the joint protection: (1) absorption of gold via skin, (2) mechanical factor, (3) constriction leading to a reduction in local tissue perfusion and/or differential drop in the finger temperature, (4) neural factors akin to stroke patients who develop less severe arthritic changes on the paralysed side, and (5) magnetic effect.
Our report is the first to demonstrate the possible protective effect of a gold ring on the DIP joint of a patient with nodal osteoarthritis. In our opinion, it is unlikely that the gold ring is sparing the DIP joint by some mechanical effect. The patient has rarely if ever removed the ring from its baseline position. Furthermore, the presence of a normal brachial to finger index at the left distal ring finger (0.95) rules out ischemic possibilities. We initially hypothesized that gold nanoparticles had infiltrated the skin to reach the DIP joint [8] and exerted anti-inflammatory and antioxidant effects in that joint [9],[10]. However, bulk gold has not yet been proven as a therapeutic transmitter of gold nanoparticles (personal oral communication with Professor Ofra Benny, The Center of Nanoscience and Nanotechnology of The Hebrew University of Jerusalem, Israel, 2022). We are therefore curious as to the potential mechanisms which may contribute to this case’s observation of the association of gold bands and Heberden’s nodal attenuation.
Prior studies do support the role of inflammation in the pathogenesis of osteoarthritis including nodal osteoarthritis of the hand [9],[10]. Injection of gold microparticles directly into osteoarthritic knee joints may provide pain relief and improved joint function [11]. The use of gold-based autologous conditioned serum injection into affected joints is now being explored as a treatment in osteoarthritis [12]. Drug delivery systems of anti-inflammatory medications for osteoarthritis have been growing in recent years [13],[14]. In vitro studies provide a strong scientific basis for intracutaneous delivery of plasmonic gold nanoparticles to treat inflammatory skin conditions [3]. On this basis, we believe that a subcutaneous delivery system of gold nanoparticles may play a role in the treatment of osteoarthritic joints. The potential cytotoxicity of gold nanoparticles is currently a matter of controversy that also requires further study [15].
Our case is the first that highlights the attenuating effect of wearing a gold ring on the expression of nodal osteoarthritis at the DIP joint. Our research of plausible explanations for this phenomenon did not generate a definite mechanism. However, the same research has led us to believe that a subcutaneous gold nanoparticle delivery system should be explored as a treatment of osteoarthritic joints.
1.
Blackburn WD. Management of osteoarthritis and rheumatoid arthritis: Prospects and possibilities. Am J Med 1996;100(2A):24S–30S. [CrossRef]
[Pubmed]
2.
Khan MA, Khan MJ. Nano-gold displayed anti-inflammatory property via NF-kB pathways by suppressing COX-2 activity. Artif Cells Nanomed Biotechnol 2018;46(sup1):1149–58. [CrossRef]
[Pubmed]
3.
Goldstein A, Soroka Y, Frušić-Zlotkin M, Lewis A, Kohen R. The bright side of plasmonic gold nanoparticles; activation of Nrf2, the cellular protective pathway. Nanoscale 2016;8(22):11748–59. [CrossRef]
[Pubmed]
4.
Bolosiu HD, Parasca I. An unusual cause of asymmetric rheumatoid involvement in the hands. Clin Rheumatol 1985;4(3):363–4. [CrossRef]
[Pubmed]
5.
Mulherin DM, Struthers GR, Situnayake RD. Do gold rings protect against articular erosion in rheumatoid arthritis? Ann Rheum Dis 1997;56(8):497–9. [CrossRef]
[Pubmed]
6.
Hlaing T, Ramteke S, Binymin K. Gold finger: Metal jewellery as a disease modifying antirheumatic therapy! Case Rep Med 2009;2009:518976. [CrossRef]
[Pubmed]
7.
BoloŞiu HD. Protective effect of gold rings and rheumatoid arthritis. Ann Rheum Dis 1998;57(5):323. [CrossRef]
[Pubmed]
8.
Friedman N, Dagan A, Elia J, Merims S, Benny O. Physical properties of gold nanoparticles affect skin penetration via hair follicles. Nanomedicine 2021;36:102414. [CrossRef]
[Pubmed]
9.
McGonagle D, Tan AL, Grainger AJ, Benjamin M. Heberden’s nodes and what Heberden could not see: The pivotal role of ligaments in the pathogenesis of early nodal osteoarthritis and beyond. Rheumatology (Oxford) 2008;47(9):1278–85. [CrossRef]
[Pubmed]
10.
Leung GJ, Rainsford KD, Kean WF. Osteoarthritis of the hand I: Aetiology and pathogenesis, risk factors, investigation and diagnosis. J Pharm Pharmacol 2014;66(3):339–46. [CrossRef]
[Pubmed]
11.
Rasmussen S, Petersen KK, Kristiansen MK, et al. Gold micro-particles for knee osteoarthritis. Eur J Pain 2022;26(4):811–24. [CrossRef]
[Pubmed]
12.
Schneider U, Kumar A, Murrell W, Ezekwesili A, Yurdi NA, Maffulli N. Intra-articular gold induced cytokine (GOLDIC®) injection therapy in patients with osteoarthritis of knee joint: A clinical study. Int Orthop 2021;45(2):497–507. [CrossRef]
[Pubmed]
13.
Yancey JR, Gill C. Topical NSAIDs for chronic musculoskeletal pain in adults. Am Fam Physician 2017;96(9):573–4.
[Pubmed]
14.
Gambaro FM, Ummarino A, Andón FT, Ronzoni F, Di Matteo B, Kon E. Drug delivery systems for the treatment of knee osteoarthritis: A systematic review of in vivo studies. Int J Mol Sci 2021;22(17):9137. [CrossRef]
[Pubmed]
15.
Sani A, Cao C, Cui D. Toxicity of gold nanoparticles (AuNPs): A review. Biochem Biophys Rep 2021;26:100991. [CrossRef]
[Pubmed]
The authors thank Dr. A. Assaf for preparing hand X-ray image for publication.
Author ContributionsMark Rabinovitch - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Elliot Kravitz - Conception of the work, Design of the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Mark Rabinovitch et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.